Berirab P 300IU Injection

Berirab P 300IU Injection Human Rabies Immunoglobulin injection (HRIG) includes Berirab P 300IU Injection as an active ingredient. It’s intended to stop the transmission of a rabid virus following exposure to animals that are rabid (dogs or mongooses, jackals or foxes). This is an injection formulated using blood plasma taken from donors that have been screened. Rabies is transmitted when someone is bitten or scratched by an infected animal, especially if the skin has already been injured. Rabies is a severe and frequently fatal viral illness that can trigger severe neurological symptoms like headache, fever, muscle weakness, and even paralysis. If symptoms are present, the condition is nearly always fatal. Although this disease is deadly in 100, it is avoidable with prompt measures and proper use of available vaccines such as immunoglobulins and monoclonal antibodies.
Patients who have a history of severe allergic responses to Berirab P300IU or its constituents should avoid this medicine. This injection is derived from the plasma of humans and may include infectious substances that may cause illness. Inform your doctor immediately if you are experiencing symptoms such as nausea, headache, vomiting, fever or weakness, muscle pain, or diarrhea since these signs may indicate a virus infection. Children require particular precautions when using Berirab P300IU injection. It can be utilized in patients who are elderly, but the dosage and method of administration could require adjustments according to weight, age, and overall health.